• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤附件恶性肿瘤的现行治疗选择。

Current Treatment Options for Cutaneous Adnexal Malignancies.

机构信息

Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, 36-1, Nishicho, Yonago, Tottori, 683-8503, Japan.

出版信息

Curr Treat Options Oncol. 2022 May;23(5):736-748. doi: 10.1007/s11864-022-00971-3. Epub 2022 Mar 26.

DOI:10.1007/s11864-022-00971-3
PMID:35347560
Abstract

Cutaneous adnexal malignancies include various types of malignant tumors that show differentiation of cutaneous appendages. They can be classified into sweat gland, hair follicle, and sebaceous gland differentiations. All types of cutaneous adnexal tumors are rare and standard treatment options based on valid evidence have not been established. Although prognosis differs depending on the type of cutaneous adnexal malignancy, surgery is the mainstay of treatment. In surgical treatment, an adequate surgical margin is unclear for wide local excision. Mohs micrographic is a better option than wide local excision in terms of margin control and cosmetic outcome because the face, head, and neck are favorable sites for some cutaneous adnexal malignancies. There has been no randomized trial of radiation therapy and chemotherapy for any cutaneous adnexal malignancies. Radiation therapy should be considered if the tumor cannot be removed surgically. Chemotherapy is one of the options for metastatic cases in some types of cutaneous adnexal malignancies, but evidence of the effectiveness of chemotherapy is lacking. Recent studies have revealed genetic mutations in this field, and target therapy and immunotherapy may be promising treatment options for unresectable cutaneous adnexal malignancies in the future.

摘要

皮肤附属器恶性肿瘤包括各种分化为皮肤附属器的恶性肿瘤。它们可以分为汗腺、毛囊和皮脂腺分化。所有类型的皮肤附属器肿瘤都很少见,并且尚未建立基于有效证据的标准治疗选择。尽管预后因皮肤附属器恶性肿瘤的类型而异,但手术是主要的治疗方法。在手术治疗中,广泛局部切除的手术切缘尚不清楚。Mohs 显微外科手术在切缘控制和美容效果方面优于广泛局部切除,因为面部、头部和颈部是某些皮肤附属器恶性肿瘤的有利部位。对于任何皮肤附属器恶性肿瘤,都没有关于放疗和化疗的随机试验。如果肿瘤不能通过手术切除,应考虑放疗。对于某些类型的皮肤附属器恶性肿瘤,化疗是转移性病例的选择之一,但缺乏化疗有效性的证据。最近的研究揭示了该领域的基因突变,针对这些突变的靶向治疗和免疫疗法可能是未来不可切除的皮肤附属器恶性肿瘤有希望的治疗选择。

相似文献

1
Current Treatment Options for Cutaneous Adnexal Malignancies.皮肤附件恶性肿瘤的现行治疗选择。
Curr Treat Options Oncol. 2022 May;23(5):736-748. doi: 10.1007/s11864-022-00971-3. Epub 2022 Mar 26.
2
Periocular cutaneous malignancies: a review of the literature.眼周皮肤恶性肿瘤:文献复习。
Dermatol Surg. 2012 Apr;38(4):552-69. doi: 10.1111/j.1524-4725.2012.02367.x. Epub 2012 Mar 8.
3
Treatment of Malignant Cutaneous Adnexal Neoplasms.恶性皮肤附属器肿瘤的治疗
Actas Dermosifiliogr (Engl Ed). 2018 Jan-Feb;109(1):6-23. doi: 10.1016/j.ad.2017.04.005. Epub 2017 Oct 6.
4
Evaluating Rates of Positive Margins After Standard Excision of Cutaneous Adnexal Malignancies.评估标准切除皮肤附件恶性肿瘤后的阳性边缘率。
Dermatol Surg. 2023 Oct 1;49(10):907-913. doi: 10.1097/DSS.0000000000003887. Epub 2023 Aug 2.
5
Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.专家病理审查对皮肤附件癌诊断的影响:来自法国 CARADERM 网络的 2573 例患者分析。
Eur J Cancer. 2022 Mar;163:211-221. doi: 10.1016/j.ejca.2021.11.027. Epub 2022 Jan 30.
6
Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients.罕见皮肤附属器恶性肿瘤的外科治疗和淋巴结活检:7591 例患者的基于人群的分析。
Arch Dermatol Res. 2021 Oct;313(8):623-632. doi: 10.1007/s00403-020-02143-5. Epub 2020 Sep 23.
7
Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome.微囊性附属器癌:48例病例、治疗及预后
Arch Dermatol. 2000 Nov;136(11):1355-9. doi: 10.1001/archderm.136.11.1355.
8
Mohs Micrographic Surgery Evaluation and Treatment of Microcystic Adnexal Carcinoma莫氏显微外科手术:微囊性附属器癌的评估与治疗
9
Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: a case series.三级癌症专科医院头颈部罕见皮肤恶性附属器肿瘤的回顾性研究:病例系列
J Med Case Rep. 2017 Mar 12;11(1):67. doi: 10.1186/s13256-017-1212-8.
10
Adnexal skin tumors in Zaria, Nigeria.尼日利亚扎里亚的附件皮肤肿瘤
Ann Afr Med. 2008 Mar;7(1):6-10. doi: 10.4103/1596-3519.55691.

引用本文的文献

1
Successful treatment of trichilemmal carcinoma with distant metastasis using pembrolizumab: a case report and review.采用派姆单抗成功治疗伴有远处转移的毛发上皮瘤:病例报告及文献复习。
Immunotherapy. 2024;16(10):659-667. doi: 10.1080/1750743X.2024.2353535. Epub 2024 May 23.

本文引用的文献

1
Pembrolizumab in the Treatment of Microsatellite Instability-High Sebaceous Carcinoma: A Case Report With Review of the Literature.帕博利珠单抗治疗微卫星高度不稳定的皮脂腺癌:一例报告并文献复习
JCO Precis Oncol. 2020 Nov;4:61-65. doi: 10.1200/PO.19.00302.
2
A Rare Case of Trichilemmal Carcinoma: Histology and Management.一例罕见的外毛根鞘癌:组织学与治疗
J Clin Aesthet Dermatol. 2021 Jun;14(6):25-30. Epub 2021 Jun 1.
3
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.
高肿瘤突变负担和 EGFR/MAPK 通路激活是转移性葡萄状肉瘤的治疗靶点。
Br J Dermatol. 2021 Dec;185(6):1186-1199. doi: 10.1111/bjd.20604. Epub 2021 Aug 18.
4
Eccrine Porocarcinoma: A Challenging Diagnostic and Therapeutic Tumoral Entity.小汗腺癌:一种具有挑战性的诊断和治疗肿瘤实体。
Case Rep Oncol. 2021 May 10;14(2):700-705. doi: 10.1159/000514984. eCollection 2021 May-Aug.
5
Hidradenocarcinoma: a rare but challenging diagnosis.汗管癌:一种罕见但具有挑战性的诊断。
Clin Imaging. 2021 Jul;75:138-142. doi: 10.1016/j.clinimag.2021.01.024. Epub 2021 Feb 2.
6
Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma.一名转移性皮肤汗腺癌患者对抗PD-1治疗的卓越反应。
Eur J Cancer. 2021 Mar;145:143-145. doi: 10.1016/j.ejca.2020.12.015. Epub 2021 Jan 16.
7
Treatment of Recurrent Primary Cutaneous Mucinous Carcinoma of the Eyelid with Modified Wide Local Excision.改良广泛局部切除术治疗复发性原发性眼睑皮肤黏液癌
Case Rep Ophthalmol Med. 2020 Dec 18;2020:6668640. doi: 10.1155/2020/6668640. eCollection 2020.
8
Common sense and tumor treatment. A case of pilomatrical carcinoma in a 21-year-old patient with surprisingly rapid tumor progression.常识与肿瘤治疗。一位 21 岁患者的毛母质瘤,肿瘤进展迅速,令人惊讶。
Oral Oncol. 2021 Jan;112:105007. doi: 10.1016/j.oraloncology.2020.105007. Epub 2020 Sep 22.
9
Localized sebaceous carcinoma treatment: Wide local excision verses Mohs micrographic surgery.局限性皮脂腺癌的治疗:广泛局部切除术与Mohs 显微外科手术。
Dermatol Ther. 2020 Nov;33(6):e13991. doi: 10.1111/dth.13991. Epub 2020 Aug 6.
10
Malignant Hidradenocarcinoma of the Axilla.腋窝恶性汗腺癌
Cureus. 2020 Feb 24;12(2):e7091. doi: 10.7759/cureus.7091.